
|Articles|April 15, 2002
Loteprednol, azelastine provide potent arsenal for acute, chronic allergic conjunctivitis
Loteprednol etabonate 0.2% (Alrex, Bausch & Lomb) and azelastine hydrochloride 0.05% (Optivar, Muro) are both valuable options for the management of seasonal and perennial allergic conjunctivitis, said Charles Slonim, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Advancements in femtosecond laser technology benefit surgeons and patients
2
ICYMI: AAO 2025 showcases new technologies and continued research
3
Precision strategy: Optimizing visual outcomes with advanced small-aperture lenses
4
What if? Ophthalmology without OCT – Part 1
5

















































.png)


